In The News
Clyde & Co sued by insurers over indemnity advice
Cornwalls hits back at $4.8M negligence suit by former client
Top silk to join NSW Supreme Court
Ex-Bulldogs player must produce messages between solicitor and doctor
Child removal class actions launched against NSW, WA
NAB accused in suit of rescinding job offer to pregnant employee
Slater & Gordon denies firing HR head for reporting underpayments
Wealth guru Dominique Grubisa pleads ignorance in appeal of $6M penalty
Court finds former Orix boss engaged in fraud, throws out suit against Chubb
Cruise operators face potential class action over onboard gambling
Please login to bookmarkClose

The Australian Securities and Investments Commission has filed court action against a multi-million dollar Western Australian biotech company, alleging it made several misleading representations to the market during the height of the COVID-19 pandemic.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au